Financial pressures that require R&D to deliver new therapies have never been more intense, and the pace of technological change is accelerating faster, well beyond the current regulatory framework.

The swell of the clinical data tsunami, created by pushing the current research frontier, is more and more prevalent as the industry seeks to consolidate and exploit voluminous legacy and ballooning clinical data repositories. The challenge and opportunity lie with the data and how it can be optimally 'commercialized' more efficiently and effectively by the greater enterprise.

Recently, a variety of emerging technologies have shown promise, with the goal of streamlining the flow of raw, clinical data, and eventually delivering submission-ready clinical data sets.